ESC Professional Premium Access

Dapagliflozin enhances arterial and venous compliance during exercise in heart failure with preserved ejection fraction

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Congress Presentation

About the speaker

Doctor Atsushi Tada

Mayo Clinic, Rochester (United States of America)
0 follower

3 more presentations in this session

Estimated transmitral E- and A-wave overlapping predicted prognosis in patient with heart failure with preserved ejection.

Speaker: Doctor K. Iwakura (Osaka, JP)

Thumbnail

Diagnosis of heart failure with preserved ejection fraction based on exercise stress echocardiography in real-world practice

Speaker: Mr Y. Tani (Maebashi, JP)

Thumbnail

Diagnosing heart failure with preserved ejection fraction in patients with unexplained dyspnoea using left ventricular pressure-volume loops at rest and on exertion

Speaker: Doctor R. Gessner (Leipzig, DE)

Thumbnail

Access the full session

Diagnosis and prognosis of HFpEF

Speakers: Doctor A. Tada, Doctor K. Iwakura, Mr Y. Tani, Doctor R. Gessner
Thumbnail

About the event

Image

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations